UBS Group’s Congress SMid Growth ETF CSMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.28K Sell
237
-256
-52% -$8.46K ﹤0.01% 8599
2025
Q4
$15.6K Buy
+493
New +$16.1K ﹤0.01% 7955
2025
Q3
Sell
-13,268
Closed -$414K 10400
2025
Q2
$414K Buy
13,268
+2,684
+25% +$78.1K ﹤0.01% 6167
2025
Q1
$293K Buy
+10,584
New +$314K ﹤0.01% 6265
2024
Q4
Sell
-109
Closed -$3.26K 9997
2024
Q3
$3.26K Sell
109
-741
-87% -$21.6K ﹤0.01% 8297
2024
Q2
$24.4K Buy
850
+109
+15% +$3.12K ﹤0.01% 7179
2024
Q1
$22.3K Buy
+741
New +$20.6K ﹤0.01% 6880

Other funds holding CSMD

UBS Group's CSMD Position: Q1 2026 in Review

UBS Group reduced its Congress SMid Growth ETF (CSMD) stake by 52% in Q1 2026, selling an estimated $8.46K and leaving 237 shares worth $7.28K. The position accounts for ﹤0.01% of the portfolio, ranked #8599.

UBS Group first reported a position in CSMD in Q1 2024 and has held it in 7 quarters since. The position peaked at $414K in Q2 2025. 37 funds tracked by Wall St. Rank hold CSMD as of Q1 2026.

  • UBS Group held 237 shares of Congress SMid Growth ETF worth $7.28K as of Q1 2026.
  • UBS Group sold 256 Congress SMid Growth ETF shares in Q1 2026, an estimated $8.46K.
  • Congress SMid Growth ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8599 holding.
  • UBS Group first reported a position in Congress SMid Growth ETF in Q1 2024 and has held it in 7 quarters since.
  • UBS Group's Congress SMid Growth ETF position peaked at $414K in Q2 2025.
  • 37 funds tracked by Wall St. Rank held Congress SMid Growth ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.